Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
FormFactor Inc. (FORM - Analyst Report) recently completed its acquisition of MicroProbe, Inc., a subsidiary of Astria Semiconductor Holdings, Inc. The company spent $100 million in cash and $16.8 million in stock for the acquisition. The deal was announced last month.
Headquartered in California, MicroProbe is the market share leader in the system on chip (SoC) probe card market, with a share of approximately 20% and has been continuously increasing its market share. Last year, the company posted non-GAAP EBITDA margin of approximately 20% and annual revenues of roughly $87.3 million, which was up 46% from the year-ago quarter.
FormFactor is already a leading supplier of memory probe cards. Its existing SoC sales are driven by the microcontroller (MCU) market, which is mostly used in auto and industrial sectors. The acquisition will strengthen FormFactor’s position in the SoC probe card market, mainly used to test chips for tablets and smartphones, where the company has been making significant investments over the past 12-18 months.
Today, the advanced SoC probe card market is the fastest growing portion of the entire probe card market. According to the market research firm, VLSI Research Inc, probe card revenue is expected to grow steadily and stay above the billion dollar mark despite severe pricing pressure over the next five years. The firm projects that the semiconductor probe card market will be worth about $1.5 billion by 2016.
Management stated that though it does not expect substantial cost synergies from the deal, the acquisition will be immediately accretive to the company financials, beginning from the first quarter of 2013.
FormFactor is an original equipment manufacturer (OEM) of wafer probe cards used by semiconductor makers to test integrated circuits. In the last-reported second quarter of 2012, the company delivered revenues of $54.8 billion, up 57.5% sequentially and 17.7% year over year. GAAP net loss was $4.2 million compared with a loss of $7.7 million in the year-ago quarter.
FormFactor has customer and market concentration that increases execution risks. Increasing competition from Advantest Corp. (ATE) and Cascade Microtech Inc. (CSCD - Snapshot Report) is also a matter of concern.
Currently, the shares of FormFactor carry a Zacks #4 Rank (short-term Sell rating).
Get the full Analyst Report on FORM - FREE
Get the full on ATE - FREE
Get the full Snapshot Report on CSCD - FREE